House > Enterprise
Mico Abarro, ABS-CBN Information
MANILA—Philippine pharmaceutical firm Unilab on Saturday mentioned it was not withholding shares of sure medicines and growing their costs amid a surge in demand.
In a press release, Unilab mentioned there was no fact to what it referred to as “rumors” that it hoarded shares of Biogesic, Bioflu, Neozep, Solmux, and Decolgen medicine used to deal with fever, coughing, and different signs of COVID-19.
Unilab mentioned an “extraordinary excessive demand” brought on provides to briefly run out “in sure areas of the nation.”
“We proceed to fabricate and have the truth is elevated the manufacturing quantity of those merchandise to serve the extraordinary demand,” the agency mentioned.
It additionally urged all Filipinos to chorus from “relying upon and passing on false information” so as to not “trigger public panic and nervousness.”
Earlier this week, the federal government restricted the acquisition of paracetamol and several other different flu remedy medicines to stop “synthetic shortages” and value hikes.
Source_link
The post ‘Not true’: Unilab says it’s not Climbing Drugs Costs appeared first on pinoytechsavy.
